Why the study?
Supraventricular tachycardias induced by dual antegrade AV node conduction are rare and often misdiagnosed, and long-term follow-up in these patients has been lacking.
Does radiofrequency catheter ablation safely and effectively treat supraventricular tachycardia in patients with dual antegrade conduction in the AV node?
Observational (n=17)
Yes
Does radiofrequency catheter ablation safely and effectively treat supraventricular tachycardia in patients with dual antegrade conduction in the AV node?
Catheter ablation of the slow pathway is a safe and highly effective treatment for patients with dual antegrade conduction in the AV node, preventing long-term arrhythmia recurrence.
Answers are grounded in this paper and cite their sources.
May support ablation feasibility in dual AV nodal conduction; leaves open confirmation via larger prospective trials.
BACKGROUND: Supraventricular tachycardias induced by dual antegrade conduction via the atrioventricular (AV) node are rare but often misdiagnosed with severe consequences for the affected patients. As long-term follow-up in these patients was not available so far, this study investigates outcomes in patients with dual antegrade conduction in the AV node. METHODS AND RESULTS: In this multicentre observational study, patients from six European centres were studied. Catheter ablation was performed in 17 patients (52 ± 16 years) with dual antegrade conduction via both AV nodal pathways between 2012 and 2018. Patients with the final diagnosis of a manifest dual AV nodal non-re-entrant tachycardia had a mean delay of the correct diagnosis of over 1 year (range 2-31 months). Two patients received prescription of non-indicated oral anticoagulation, two further patients suffered from inappropriate shocks of an implantable cardioverter defibrillator. In 12 patients, a co-existence of dual antegrade and re-entry conduction in the AV node was present. Mean fast pathway conduction time was 138 ± 61 ms and mean slow pathway conduction time was 593 ± 134 ms. Successful radiofrequency catheter ablation was performed in all patients. Post-procedurally oral anticoagulation was discontinued, without detection of cerebrovascular events or atrial fibrillation during a long-term follow-up of median 17 months (range 6-72 months). CONCLUSION: This first multicentre study investigating patients with supraventricular tachycardia and dual antegrade conduction in the AV node demonstrates that catheter ablation is safe and effective while long-term patient outcome is good. Autonomic tone dependent changes in ante- vs. retrograde conduction via slow and/or fast pathway can challenge the diagnosis and therapy in some patients.
No takes yet. Share an insight, caveat, or question.
Hartmann et al. (2020) conducted an observational in Dual antegrade conduction in the atrioventricular node (DAVNNT) (n=17). Radiofrequency catheter ablation was evaluated on Acute procedural success and long-term recurrence of supraventricular tachycardia, atrial fibrillation, or cerebrovascular events.
Synapse has enriched 10 related papers. Consider them for comparative context: